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ABSTRACT 
Microsponge type of drug delivery is the latest technology which has been introduced in topical skin care, drug products to facilitate 
the controlled release of the active medicament into the skin in order to reduce systemic exposure and control local cutaneous 
reactions to active drugs. Microsponge can be loaded into a topical route of drug delivery system for the residue of dosage form of 
skin and thus controlled release drug delivery system is achieved and in return improving the patient compliance by providing target 
drug delivery system and prolonging dosage intervals. Microsponge is polymeric delivery systems composed of porous 
microspheres. They are tiny sponge-like spherical particles and posses large porous surface area. Furthermore, they may enhance 
stability, reduce side effects, improve patient compliance and modify drug release. Microsponges are the polymer-based 
microspheres system that has the capacity to entrap a wide variety of substances, and can then be incorporated into a different 
formulation. 
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Microsponge is Neoteric technology, which provides 
extended release of pharmaceutical active ingredients
 1, 2 
and mostly used for topical administration. Now a day 
the major challenge to the pharmaceutical industry is to 
control the rate of delivery of active pharmaceutical 
ingredient to a pre-determined site. So to improve 
efficacy and patient compliance, researcher focused on 
designing of different controlled release drug delivery 
systems. In 1987, Won was developed the microsponge 
technology and the original patents were authorized by 
Advanced Polymer System, Inc.
3 
Microsponge having a 
myriad of interconnected size ranging voids of particle 
from 5-150 μm.4 The main purpose of this delivery 
system to achieved desired concentration of the drug in 
blood in the microsponge delivery systems which is 
therapeutically more effective and non-toxic for long 
periods in the recent study. Primarily microsponge is the 
use for transdermal drug delivery system.
5, 6
 Various 
methods for preparation of microsponge drug delivery 
systems studied. 
A typical 25 μm sphere can have up to 250000 pores 
and have an internal pore structure equivalent to 10 feet 
in length and this results in a large reservoir type system 
within each microsponge, which can be loaded with up 
to its own weight of the active agent. The microsponge 
particles are too large to be absorbed into the skin.
7, 8
 
Properties of drug for loading into microsponge
 9, 10, 
11 
 
1. It must be fully miscible in monomer otherwise, 
should be made miscible by addition of a small 
amount of a water immiscible solvent.  
2. It should be watered immiscible or at most only 
slightly soluble.  
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3.  With respect to monomers it should be inert.  
4. The solubility of active ingredients in the vehicle 
must be checked to avoid cosmetic problems; 
otherwise the vehicle will evacuate the microsponge 
before the application.  
5. The spherical structure of microsponge should not 
faint. 
6. Design of Polymer for the active must be optimized 
for a given time period for required release rate. It 
must be stable in contact with polymerization 
catalyst and states of polymerization. 
Advantages of microsponge drug delivery system
 12 
1. Microsponge is act as a controlled drug delivery 
system.   
2. Drug directly applied to target organs.   
3. It increases stability of drugs.   
4. These are capable of absorbing skin secretions and 
lessen the oiliness. 
5. Enhanced product performance.    
6. Reduced irritation and hence improved patient 
compliance. 
7. Improved product elegance.   
8. It can improve efficacy in the treatment.  
9. It can also improve bioavailability of the drugs  
10. Flexibility to develop novel product forms.  
11. MDS has a wide range of chemical stability and 
are easy to formulate. 
12. Microsponge systems are non-irritating, non-
mutagenic, non-allergenic and non-toxic.  
13. Microsponge system can reduce significantly the 
irritation of effective drugs  
14. Without reducing their efficacy, it can prevent 
excessive accumulation of ingredients within the 
skin surface.  




o Improved oil control as it can absorb oil up to 6 
times its weight.  
o Microsponge system compatible with vehicles and 
active ingredients. 
o  Self sterilizing as average pore size is 0.25µm 
where bacteria cannot penetrate. 
o These are non-irritating, non mutagenic, non 
allergenic and nontoxic.                               
o Release is extended up to 12 hours. 
o Microsponge system stable in the range of pH 1 to 
11, temperature up to 130 ºC. 
o Liquids can be converted into powders by 
improving material processing. 
 
Figure 1: Programmable release from microsponges 
Pressure triggered systems
14 
    
Microsponge system releases the entrapped material 
when pressurized/rubbed; the amount released depends 
upon special characteristics of the sponge. The 
microsponge best suited for a given application may be 
optimized by varying the type of material and different 




Some active ingredients loaded in microsponge can be 
too viscous at room temperature to flow spontaneously 
into the skin. The flow rate can be increased by 





So it is possible to regulate the release of substances 
from the microsponge by modulation of temperature.  
pH triggered systems   
Triggering the pH-based release of the active can be 
achieved by modifying the coating on the microsponge. 




 Microsponge loaded with water-soluble ingredients will 
release the ingredient in the presence of water. The 
release rate of active ingredients can be triggered in the 
presence of aqueous medium. This release may be 
achieved based on the ability of the external medium to 
dissolve the active, the concentration gradient or the 
capability to swell the microspore network. 
Drugs explored in the microsponge delivery system
19, 
20, 21, 22 
Paracetamol                                     Miconazole      
Benzoyl peroxide                            Curcumin 
Ketoprofen                                      Tretinoin 
Fluconazole                                     Hydroquinone 
Acyclovir sodium                            Ibuprofen 
Retinol                                             Prednisolone       
Erythromycin                  Indomethacin  
Mupirocin  
Polymers used for the preparation of microsponges 
 Eudragit RS 100 and RL 100    
 Ethylcellulose 
 Polystyrene 
 Acrylic polymer 
 PHEMA 
 Carbopol 934 
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Based on physico-chemical properties of 
drug to be loaded
Figure 2: One step and two step preparation of 
microsponges  
1. Liquid-liquid suspension polymerization28,29,30  
The porous microsphere based microsponges are 
prepared by the suspension polymerization method. In 
this polymerization technique the immiscible monomers 
are first dissolved with active ingredients in a suitable 
solvent and are then dispersed in the aqueous phases 
which consist of surfactant or suspending agents that are 
used for the formation of suspension. The 
polymerization is then activated by increasing 
temperature or irradiation or by addition of catalyst. The 
polymerization process continues until the reservoir type 
of system with spherical structure is formed. After the 






Figure 3: Formation of Suspension for Preparation of Liquid-Liquid Suspension Polymerization. 
2. Quasi-emulsion solvent diffusion31, 32, 33 
Quasi-emulsion solvent diffusion technique (two-step 
process) is used for the preparation of Porous 
microsphere (microsponges). In this method an inner 
phase containing polymer such as eudragit dissolved in 
solvent like ethyl alcohol. The drug is slowly added to 
the polymer solution, then dissolved under 
ultrasonication at the temperature 35
o
C and plasticizer 
such as triethylcitrate (TEC) is added in order to assist 
the plasticity. The inner phase is then poured into 
external phase containing polyvinyl alcohol and distilled 
water with continuous stirring for 2 to 3 hours. Then, the 
mixture is filter to separate the microsponges. The 
microsponges is then washed and dried in an oven at 
40°C for 10 to 12 h. 
  
 
Figure 4: Quasi-emulsion solvent diffusion method. 
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MECHANISM OF ACTION 
34 
The active ingredients are added to the vehicle in an
entrapped form
The active is free to move in and out from particles and into
the vehicle as they have an open structure and the vehicle
becomes saturated at equilibrium state
Once the product is applied to the skin, the active will be
absorbed into the skin, depleting the vehicle, which become
unsaturated, thus disturbing the equilibrium.
A flow of microsponge particle to vehicle and from vehicle
to skin, until the vehicle is either absorbed or dried.
Figure 5: Release of mechanism of microsponge drug delivery
 
Figure 5: Release mechanism of microsponge drug delivery 
Table 1: Optimum values for microsponges formulation 
Sr.no    Specification     Optimum value     
1  Drug and polymer ratio  1:1,1:2,1:3, 2:1& 3:1     
2  Amount of drug (mg)  100-300    
3  Polyvinylalcohol (mg)  100  
4  Inner phase solvent (ml)  Ethyl alcohol     
5  Amount of inner phase solvent  10  
6  Amount of water in outer phase (ml)  100  
7  Temperature of inner phase     25ºC     
8  Type of process  Magnetic stirrer and bath sonicator  
9  magnetic stirrer speed  1000 rpm     
 




Particle size evaluation-The particle size distribution is 
evaluated using optical microscope or electron 
microscope. Particle size determination of Microsponge 
can be performed by laser light diffractometry or other 
suitable method. The values (d 50) can be expressed for 
all formulations as mean size ranges. Particle size 
greater than 30 µm can give gritty feeling and hence 
particles sizes between 10 and 25 µm are used in the 
final formulation. 
Morphology and surface topography- In the 
morphological study of microsponge topography various 
techniques are used such as the photon correlation 
spectroscopy (Pcs), Transmission electron spectroscopy 
(TEM), scanning electron microscopy (SEM). 
Determination of loading efficiency:  The loading 
efficiency (%) of the microsponges can be calculated as 
follows:-  
     
                  
 
                                 
                       
     
Determination of production yield: The production 
yield of the microsponges can be determined by: 
 
                
 
                            
                                
     
 
Determination of true density- The true density of the 
microsponge can be measured using an ultra-
pycnometer in the presence of helium gas and is 
calculated from a mean of repeated determinations.   
Compatibility study- It can be studied by thin layer 
chromatography (TLC) and Fourier Transform Infra-red 
spectroscopy (FT-IR). Effect of polymerization on the 
crystallinity of drug can be studied by powder X-ray 
diffraction (XRD) and differential scanning calorimetric.   
Release evaluation: Release of microsponges can be 
controlled through diffusion or other triggering 
mechanism such as moisture, pH, friction, temperature. 
This release mechanism used to enhance product 
aesthetics.  
Resiliency: For the production of bullets a particle that 
is softer or firmer according to the needs of the final 
formulation viscoelastic properties of the microsponge 
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can be modified. Increased cross-linking tends to 
decrease the rate of release.   
Stability study: Gel formulation is subject to stability 
testing as per ICH norms. Gel fill in clean, lacquered, 
collapsible aluminum tubes, and various replicates kept 
at 40 ± 2°C and 75 ± 5% relative humidity in a humidity 
Chamber. Gel assessed for change in appearance, pH 
and in vitro release profile at an interval of 30, 60 and 
90 days. 
APPLICATION OF MICROSPONGE  
It offers the formulator range of alternative to develop 
the drug and cosmetic products. Over-the-counter 
products that incorporate microsponge drug delivery 
system include numerous moisturizers, specialized 
rejuvenated products, and sunscreens.
 38-42 
Topical drug delivery using microsponge 
technology
43
 - (A) Benzoyl peroxide (BPO) is 
commonly used in topical formulations for the treatment 
of acne and athlete’s foot. Controlled release of BPO of 
the microsponge delivery system to the skin could 
reduce the side effect. 
(B) A Microsponge based topical formulation of 
mupirocin, used as antibiotic for skin infection, to 
achieve sustained drug release. The increased absorption 
of mupirocin in the skin from microsponge delivery 
system suggests the delivery system to be an efficient 
system for treatment of primary and secondary skin 
infections as compared to conventional mupirocin 
emulgel and marketed mupirocin ointment. 
Oral drug delivery using microsponge technology- 
The Microsponge system provides the controlled 
delivery of oral medications to the lower gastrointestinal 
tract, where upon exposure to specific enzymes it will 
be released in the colon. It has been shown that 
microsponge system enhances the solubilization of 
poorly soluble drugs by entrapping these drugs in their 
pores. Controlled oral delivery of ketoprofen prepared 
with Eudragit RS100 by quasi emulsion solvent 
diffusion method and subsequently tablet of 
microsponge was prepared by the direct compression 
method results show that compressibility was much 
improved in the physical mixture of the drug and the 




Microsponge used for bone and tissue engineering-  
Bone like compounds were obtained by the mixing 
prepolymerized powder of polymethyl methacrylate 
monomer with two aqueous dispersion of tricalcium 
phosphate grains and calcium deficient hydroxyapatite 
powders. The final compound appeared to be porous and 
developed as microsponge. 
 
Table 2: List of marketed products based on microsponges 
51, 52, 53 
Product Name Pharmaceutical Uses  Manufacturer 
Glycolic Acid Moisturizer w/SPF 15  Anti-Wrinkles, soothing AMCOL Health & Beauty Solution 
Retin A Micro  Acne vulgaris Ortho-McNeil Pharmaceutical, Inc 
Line Eliminator Dual Retinol Facial Treatment  Anti-wrinkle Avon 
Retinol 15 Night cream  Anti-wrinkles Sothys 
Retinol cream  Helps maintain healthy skin Biomedic 
EpiQuin Micro  Hyper pigmentation SkinMedica Inc 
Sports cream RS and XS Anti-inflammatory Embil Pharmaceutical Co. Ltd. 
Salicylic Peel 20  Excellent exfoliation Biophora 
Oil free matte block SPF 20  Sunscreen Dermalogica 
Lactrex™12%  Moisturizing Cream SDR Pharmaceuticals, Inc 
Ultra Guard Protects baby’s skin Scott Paper Company 
 
Table 3: Patents filed on microsponges
 57 
t  Patent Number Patent Name 
5100783 Weighted microsponge for immobilizing bioactive material 
1288370 Weighted collagen microsponge 
4997753 Weighted collagen microsponge for immobilizing bioactive material 
1275955 Weighted microsponge 
4863856 Weighted collagen microsponge for immobilizing bioactive materials 
4861714 Weighted collagen microsponge for immobilizing bioactive material 
0217917 Weighted microsponge for immobilizing bioactive material 
1986056694 Weighted microsponge for immobilizing bioactive material 
WO/1986/005811 Weighted microsponge for immobilizing bioactive material 
4092381 Methods of fabricating microsponge deuterated hydrocarbon polymer 
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FUTURE EXPECTANCY  
Microsponge is the present day novel technology, which 
is the mostly developed for the topical delivery system 
and recently for oral administration. It provides various 
kinds of advantages. Microsponges are carefully 
designed pharmaceutical active ingredient that deliver 
the drug effectively at the target site with the minimum 
dose and also to enhance stability, reduce side effects 
and control drug release. The real face off in the future is 
the development of the delivery system for the oral 
peptide delivery by altering the ratio of polymers. 
Microsponges will be an excellent drug delivery system. 
Microsponges drug delivery system that can accurately 
control the release rates to the specific sites of the body 
will be sought in great detail in the years to come that 
have an immense on the health care system and. Some 
microsponge related products are already approved; 
several products are currently under development and 
clinical assessment.  
CONCLUSION 
The microsponge delivery system is a novel technology 
for the controlled release of macroporous beads, loaded 
with an active agent, offering a potential reduction in 
side effects and maintaining their therapeutic efficacy. 
The microsponge drug delivery system is believed to 
reduce side effects, improved stability, increased 
elegance, enhanced formulation flexibility and also 
offers entrapment of its ingredients. Microsponge 
systems are non-irritating, non-mutagenic, non-
allergenic, and nontoxic. This technology is being used 
currently in cosmetics, over-the-counter skin care, 
sunscreens, and prescription products. This kind of drug 
delivery technology may lead to a better understanding 
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